Onderneming Black Diamond Therapeutics, Inc. OTC Markets
Aandelen
BDTX
US09203E1055
Biotechnologie & Medisch Onderzoek
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
- USD | -.--% | -.--% | -.--% |
16/05 | BLACK DIAMOND THERAPEUTICS, INC. : HC Wainwright handhaaft koopadvies | ZM |
09/05 | Black Diamond Therapeutics, Inc. rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024 | CI |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Elizabeth Buck
FOU | Founder | 49 | 01-01-14 |
Mark Velleca
CEO | Chief Executive Officer | 60 | 09-08-21 |
David Epstein
FOU | Founder | 65 | 01-01-14 |
Fang Ni
DFI | Director of Finance/CFO | 37 | 04-08-20 |
Sergey Yurasov
CTO | Chief Tech/Sci/R&D Officer | 55 | 01-06-22 |
Chief Operating Officer | 59 | 29-05-19 | |
Julie Seidel
IRC | Investor Relations Contact | - | - |
Melanie Morrison
PRN | Corporate Officer/Principal | - | 01-10-22 |
Human Resources Officer | 52 | 22-02-22 | |
Erika Jones
AUD | Comptroller/Controller/Auditor | 39 | 01-10-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Epstein
FOU | Founder | 65 | 01-01-14 |
Mark Velleca
CEO | Chief Executive Officer | 60 | 09-08-21 |
Ali Behbahani
BRD | Director/Board Member | 48 | 01-12-18 |
Garry Menzel
BRD | Director/Board Member | 59 | 01-01-14 |
Kapil Dhingra
BRD | Director/Board Member | 64 | 19-01-21 |
Samarth Kulkarni
BRD | Director/Board Member | 45 | 01-12-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 56 252 794 | 54 935 052 ( 97,66 %) | 0 | 97,66 % |
Bedrijfsgegevens
Black Diamond Therapeutics, Inc.
One Main Street 14th floor
02142, Cambridge
+
http://www.blackdiamondtherapeutics.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,99% | 115 mld. | |
+12,01% | 106 mld. | |
-3,07% | 24,69 mld. | |
-0,06% | 21,97 mld. | |
-4,69% | 19,27 mld. | |
-6,90% | 17,56 mld. | |
-39,36% | 17,32 mld. | |
+5,82% | 14,03 mld. | |
+33,05% | 12,13 mld. |
- Beurs
- Aandelen
- Koers BDTX
- Koers BDTX
- Onderneming Black Diamond Therapeutics, Inc.